Nancy
A
"Novavax's authorization today means people will now have the choice of a protein-based non-MRNA option to help protect themselves against COVID-19, which is now the fourth leading cause of death in the U.S.," Novavax's CEO John Jacobs said in a statement.
05:04 AM - Oct 04, 2023
Avatar Avatar
0
0
2

 

{{ notificationModalContent }} {{ promptModalMessage }}